Insulin analogues dosing and costs - comparing real-life daily doses of insulin detemir and insulin glargine in type 2 diabetes patients
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1472-6823
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Insulin analogues dosing and costs - comparing real-life daily doses of insulin detemir and insulin glargine in type 2 diabetes patients ; volume:12 ; number:1 ; day:25 ; month:9 ; year:2012 ; pages:1-6 ; date:12.2012
BMC endocrine disorders ; 12, Heft 1 (25.9.2012), 1-6, 12.2012
- Creator
-
Jakobsen, Marie
- Contributor
-
Dalsgaard, Mette
Hørmann, Morten
Møller, Daniél Vega
SpringerLink (Online service)
- DOI
-
10.1186/1472-6823-12-21
- URN
-
urn:nbn:de:1111-2016071629103
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:46 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Jakobsen, Marie
- Dalsgaard, Mette
- Hørmann, Morten
- Møller, Daniél Vega
- SpringerLink (Online service)
Other Objects (12)
MYL1501D Insulin Glargine: A Review in Diabetes Mellitus
Risk of cancer in patients on insulin glargine and other insulin analogues in comparison with those on human insulin: results from a large population-based follow-up study
Differences in metabolic and mitogenic signalling of insulin glargine and insulin aspart B10 in rats
Improved glycaemic control by switching from insulin NPH to insulin glargine: a retrospective observational study
Comparison between Insulin Glargine and Insulin Detemir in Adolescents with Type 1 Diabetes during Ramadan Fasting
Lilly Insulin Glargine Versus Lantus® in Insulin-Naïve and Insulin-Treated Adults with Type 2 Diabetes: A Randomized, Controlled Trial (ELEMENT 5)
Effect of the long-acting insulin analogues glargine and degludec on cardiomyocyte cell signalling and function
Correction to: MYL1501D Insulin Glargine: A Review in Diabetes Mellitus
Penicillin und Insulin: Insulin.- Bedarf
A Multinational, Randomized, Open-label, Treat-to-Target Trial Comparing Insulin Degludec and Insulin Glargine in Insulin-Naïve Patients with Type 2 Diabetes Mellitus
Review on the In Vitro Interaction of Insulin Glargine with the Insulin/Insulin-like Growth Factor System: Potential Implications for Metabolic and Mitogenic Activities
Insulin
MYL1501D Insulin Glargine: A Review in Diabetes Mellitus
Risk of cancer in patients on insulin glargine and other insulin analogues in comparison with those on human insulin: results from a large population-based follow-up study
Differences in metabolic and mitogenic signalling of insulin glargine and insulin aspart B10 in rats
Improved glycaemic control by switching from insulin NPH to insulin glargine: a retrospective observational study
Comparison between Insulin Glargine and Insulin Detemir in Adolescents with Type 1 Diabetes during Ramadan Fasting
Lilly Insulin Glargine Versus Lantus® in Insulin-Naïve and Insulin-Treated Adults with Type 2 Diabetes: A Randomized, Controlled Trial (ELEMENT 5)
Effect of the long-acting insulin analogues glargine and degludec on cardiomyocyte cell signalling and function
Correction to: MYL1501D Insulin Glargine: A Review in Diabetes Mellitus
Penicillin und Insulin: Insulin.- Bedarf
A Multinational, Randomized, Open-label, Treat-to-Target Trial Comparing Insulin Degludec and Insulin Glargine in Insulin-Naïve Patients with Type 2 Diabetes Mellitus
Review on the In Vitro Interaction of Insulin Glargine with the Insulin/Insulin-like Growth Factor System: Potential Implications for Metabolic and Mitogenic Activities
Insulin
MYL1501D Insulin Glargine: A Review in Diabetes Mellitus
Risk of cancer in patients on insulin glargine and other insulin analogues in comparison with those on human insulin: results from a large population-based follow-up study
Differences in metabolic and mitogenic signalling of insulin glargine and insulin aspart B10 in rats
Improved glycaemic control by switching from insulin NPH to insulin glargine: a retrospective observational study
Comparison between Insulin Glargine and Insulin Detemir in Adolescents with Type 1 Diabetes during Ramadan Fasting
Lilly Insulin Glargine Versus Lantus® in Insulin-Naïve and Insulin-Treated Adults with Type 2 Diabetes: A Randomized, Controlled Trial (ELEMENT 5)
Effect of the long-acting insulin analogues glargine and degludec on cardiomyocyte cell signalling and function
Correction to: MYL1501D Insulin Glargine: A Review in Diabetes Mellitus
Penicillin und Insulin: Insulin.- Bedarf
A Multinational, Randomized, Open-label, Treat-to-Target Trial Comparing Insulin Degludec and Insulin Glargine in Insulin-Naïve Patients with Type 2 Diabetes Mellitus
Review on the In Vitro Interaction of Insulin Glargine with the Insulin/Insulin-like Growth Factor System: Potential Implications for Metabolic and Mitogenic Activities